Pacira BioSciences Publishes Two-Year Phase 1 PCRX-201 Knee OA Data
BRISBANE, Calif., August 6, 2026 Pacira BioSciences announced the publication of positive two-year Phase 1 clinical trial results for...
Knee Osteoarthritis
Advertisement
Pathos AI Partners with AstraZeneca to Advance AZD4241 for ER+ Breast Cancer
NEW YORK, Aug. 4, 2026 Pathos AI announced a collaboration and co-exclusive licensing agreement with AstraZeneca to advance AZD4241,...
4Moving Biotech Targets Synovitis with Intra-Articular GLP-1 Therapy
LILLE & PARIS, France, Aug. 4, 2026 4Moving Biotech (4MB) announced the completion of patient enrollment in the Phase...
Levicept’s LEVI-04 Shows Disease-Modifying Potential in Osteoarthritis
SANDWICH, UK, June 3, 2026 Levicept Ltd announced new data from its Phase 2 clinical trial of LEVI-04, a...
OrthoTrophix TPX-100 Shows Breakthrough in Knee OA Study
Foster City, California | April 24, 2026 OrthoTrophix has unveiled compelling new clinical findings highlighting the structural relationship between...
Advertisements
OvertureTi Knee System Reaches $1M Sales Milestone
Irvine, California | December 30, 2025 — Overture Orthopaedics, a U.S.-based medical device company specializing in joint preservation technologies,...
MEDIPOST Secures Japan Commercial Deal for CARTISTEM® Therapy
Seoul, South Korea, December 19, 2025 — MEDIPOST Co., Ltd., a fully integrated cell therapy biotechnology company, has entered...
NEXTBIOMEDICAL Launches U.S. Pivotal Trial for Nexsphere-F™ in Knee OA
SEOUL, South Korea, Oct. 13, 2025 — NEXTBIOMEDICAL CO., LTD. (KOSDAQ: 389650), a South Korea-based innovative medical device company,...
Advertisement
